QA: Eton Pharmaceuticals Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001710340_2023_Eton_Pharmaceuticals_Inc.pdf

Logs

Graph

Absolute values for 0001710340, Eton Pharmaceuticals Inc.

  xvar xval
0 AssetsCurrent 20,004,000
1 IntangibleAssetsNetIncludingGoodwill 4,754,000
2 PropertyPlantAndEquipmentNet 72,000
3 remainder_Assets 200,000
4 LiabilitiesCurrent 6,461,000
5 LiabilitiesNoncurrent 107,000
6 remainder_Liabilities 5,384,000
7 CostOfGoodsAndServicesSold 6,933,000
8 SellingGeneralAndAdministrativeExpense 18,582,000
9 ResearchAndDevelopmentExpense 3,996,000
10 remainder_Expenses 0
11 remainder_Revenues 21,251,000
12 remainder_NetIncome -761,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 25,030,000
1 Liabilities 11,952,000
2 Expenses 29,511,000
3 Revenues 21,251,000
4 StockholdersEquity 13,078,000
5 NetIncome -9,021,000
6 ComprehensiveNetIncome -9,021,000
7 BaseVar 44,252,500
8 EconomicCapitalRatio 0.729

Edgar->Model Mapping

Feature Distribution

Change over Time